Operating Lease, Payments in USD of Freeline Therapeutics Holdings plc from Q1 2022 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Freeline Therapeutics Holdings plc quarterly/annual Operating Lease, Payments history and change rate from Q1 2022 to Q1 2023.
  • Freeline Therapeutics Holdings plc Operating Lease, Payments for the quarter ending March 31, 2023 was $765K, a 75.8% decline year-over-year.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Change (%)
Operating Lease, Payments, Annual (USD)

Freeline Therapeutics Holdings plc Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $765K -$2.4M -75.8% Jan 1, 2023 Mar 31, 2023 6-K 2023-05-30
Q1 2022 $3.16M Jan 1, 2022 Mar 31, 2022 6-K 2023-05-30

Freeline Therapeutics Holdings plc Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $10.5M Jan 1, 2022 Dec 31, 2022 20-F 2023-04-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.